Bay Shore Trust's Form 4 filing
Mira Pharmaceuticals, Inc. (MIRA) · filed Aug 30, 2024
- Accession no.
- 0001493152-24-034584
- Filed
- Aug 30, 2024, 4:05 PM ET
- Trade date
- Aug 28, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $392.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Bay Shore TrustCIK 0001986593 | 10% Owner |
| McNulty Brian PatrickCIK 0001996353 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 28, 2024 | Common Stock | SSaleDisposed | −200,000 | $1.96 | −$392,000 | 2,540,270 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.